NEW YORK, Feb. 6, 2026 /PRNewswire/ — As Valentine’s Day approaches, Monport Laser is highlighting how desktop laser engravers, industrial CO2 laser engraver cutting machines, and fiber laser engravers are increasingly used for customized gifts and personalized products. The company’s Valentine’s Day Sale, running Feb. 5 through Feb. 16, 2026, combines reward points, sitewide discounts, and product-specific […]
Category Archives: Pr Newswire
Revenue, Adjusted EBITDA and MarketshareContinued to Grow to All-Time High HONG KONG, Feb. 6, 2026 /PRNewswire/ — MGM China Holdings Limited (“MGM China” or the “Company”; SEHK Stock Code: 2282) today announced the selected unaudited financial data of the Company and its subsidiaries (the “Group”) for the 12 months ended December 31, 2025 (the “Year”). The […]
05
Feb
Feb
RESEARCH TRIANGLE PARK, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its fourth quarter 2025 financial results on Thursday, February 26, 2026. BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a […]
05
Feb
Feb
WELLESLEY HILLS, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that members of its executive team will participate in the upcoming conferences detailed below. Guggenheim’s Emerging Outlook: Biotech SummitFormat: Fireside ChatDate: Thursday, February 12, 2026Time: 3:00 – […]
05
Feb
Feb
SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) — Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech […]
Pr Newswire
Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant
05
Feb
Feb
Phase 2 data demonstrate differentiated CXCR4 inhibition kinetics enabling same-day cell collection, with rapid lymphocyte mobilization supporting potential therapeutic applications beyond transplant REDWOOD CITY, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced the publication of results from a prior Phase 2 […]
05
Feb
Feb
SAN MATEO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences. Guggenheim Emerging Outlook: Biotech Summit 2026 in New York, NY, on February 11, 2026, with a fireside […]
DUBAI, UAE, Feb. 5, 2026 /PRNewswire/ — Messari has released its State of Mantle Q4 2025 report, providing an in-depth analysis of Mantle’s network design, treasury strategy, and ecosystem development as the protocol advances its role as a coordinated distribution layer for institutional onchain finance. Mantle’s Evolution Into an Institutional Distribution Layer for Onchain Finance, […]
TOKYO and SHANGHAI, Feb. 5, 2026 /PRNewswire/ — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Shanghai Henlius Biotech, Inc. (Headquarters: Shanghai, China, CEO: Jason Zhu, “Henlius”) announced today the conclusion of an exclusive commercialization and co-exclusive development and manufacturing license agreement for the anti-PD-1 antibody serplulimab (generic name, marketed as HANSIZHUANG in China and Hetronifly® in the EU) in Japan. […]
SINGAPORE, Feb. 5, 2026 /PRNewswire/ — Dyna.Ai, a global provider of AI solutions, today released a new executive insights report, developed in collaboration with GXS Partners and Smartkarma, examining why most banks struggle to translate AI investment into revenue, and how a small group is breaking through. The report highlights how financial institutions across Southeast Asia, […]